Topical carmustine (BCNU) in the treatment of mycosis fungoides
HS Zackheim - Dermatologic Therapy, 2003 - Wiley Online Library
HS Zackheim
Dermatologic Therapy, 2003•Wiley Online LibraryThe University of California, San Francisco (UCSF), experience with topical carmustine
(BCNU) in the treatment of approximately 200 patients with mycosis fungoides (MF) is
summarized. Topical BCNU is an effective treatment for patch‐and early plaque‐stage MF.
Side‐effects are usually not a major deterrent to continuation of therapy.
(BCNU) in the treatment of approximately 200 patients with mycosis fungoides (MF) is
summarized. Topical BCNU is an effective treatment for patch‐and early plaque‐stage MF.
Side‐effects are usually not a major deterrent to continuation of therapy.
Abstract
The University of California, San Francisco (UCSF), experience with topical carmustine (BCNU) in the treatment of approximately 200 patients with mycosis fungoides (MF) is summarized. Topical BCNU is an effective treatment for patch‐ and early plaque‐stage MF. Side‐effects are usually not a major deterrent to continuation of therapy.
Wiley Online Library